Glenview Capital Management’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$24.4M Buy
4,587,407
+687,857
+18% +$3.65M 0.68% 28
2025
Q1
$34.6M Sell
3,899,550
-257,774
-6% -$2.29M 0.85% 24
2024
Q4
$57M Buy
4,157,324
+2,895,794
+230% +$39.7M 1.44% 23
2024
Q3
$34.6M Sell
1,261,530
-2,486,902
-66% -$68.1M 0.67% 27
2024
Q2
$91.7M Sell
3,748,432
-1,195,163
-24% -$29.2M 1.8% 15
2024
Q1
$105M Sell
4,943,595
-340,387
-6% -$7.26M 1.84% 15
2023
Q4
$101M Buy
5,283,982
+1,500,000
+40% +$28.7M 2.16% 14
2023
Q3
$60.7M Buy
3,783,982
+39,094
+1% +$627K 1.37% 23
2023
Q2
$86.8M Sell
3,744,888
-450,224
-11% -$10.4M 1.96% 14
2023
Q1
$97.5M Buy
4,195,112
+1,097,344
+35% +$25.5M 2.14% 16
2022
Q4
$44.9M Buy
3,097,768
+1,636,284
+112% +$23.7M 1% 25
2022
Q3
$27.9M Sell
1,461,484
-235,307
-14% -$4.49M 0.7% 33
2022
Q2
$30.8M Sell
1,696,791
-40,218
-2% -$731K 0.77% 29
2022
Q1
$43.8M Buy
1,737,009
+57,262
+3% +$1.44M 0.89% 31
2021
Q4
$46.4M Sell
1,679,747
-555,421
-25% -$15.3M 0.99% 32
2021
Q3
$72.2M Sell
2,235,168
-240,912
-10% -$7.78M 1.31% 24
2021
Q2
$75.7M Sell
2,476,080
-93,353
-4% -$2.85M 1.25% 28
2021
Q1
$78.2M Sell
2,569,433
-1,113,258
-30% -$33.9M 1.33% 21
2020
Q4
$72.8M Buy
3,682,691
+924,698
+34% +$18.3M 1.67% 17
2020
Q3
$36M Buy
2,757,993
+947,266
+52% +$12.4M 1.13% 21
2020
Q2
$20.5M Buy
1,810,727
+271,196
+18% +$3.08M 0.57% 34
2020
Q1
$22M Sell
1,539,531
-1,905,264
-55% -$27.3M 0.6% 34
2019
Q4
$93.8M Sell
3,444,795
-238,511
-6% -$6.49M 0.82% 31
2019
Q3
$105M Buy
+3,683,306
New +$105M 1.11% 33